TY, L., PC, L., YC, S., WF, H., SW, L., CW, C., . . . YH, H. (2026). Addition of Intra-Arterial Therapy to Immunotherapy Improves Outcomes in Unresectable Hepatocellular Carcinoma: Taiwan Multicenter Cohort Study. Liver cancer. https://doi.org/10.1159/000552375
Chicago Style (17th ed.) CitationTY, Lee, et al. "Addition of Intra-Arterial Therapy to Immunotherapy Improves Outcomes in Unresectable Hepatocellular Carcinoma: Taiwan Multicenter Cohort Study." Liver Cancer 2026. https://doi.org/10.1159/000552375.
MLA (9th ed.) CitationTY, Lee, et al. "Addition of Intra-Arterial Therapy to Immunotherapy Improves Outcomes in Unresectable Hepatocellular Carcinoma: Taiwan Multicenter Cohort Study." Liver Cancer, 2026, https://doi.org/10.1159/000552375.
Warning: These citations may not always be 100% accurate.
